KZR

Kezar Life Sciences (KZR)

About Kezar Life Sciences (KZR)

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.

Details

Daily high

$6.75

Daily low

$6.35

Price at open

$6.49

52 Week High

$11.35

52 Week Low

$5.20

Market cap

46.5M

Dividend yield

0.00%

Volume

75,106

Avg. volume

60,336

P/E ratio

-.49

Kezar Life Sciences News